These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1628605)

  • 1. Studies on an apolipoprotein C-II variant occurring in Caucasians.
    Menke-Möllers I; Kurth J; Oette K
    Electrophoresis; 1992 Apr; 13(4):244-51. PubMed ID: 1628605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid assessment of the distribution of apolipoproteins C-II and C-III subspecies in triglyceride-rich lipoproteins by isoelectric focusing.
    Bugugnani MJ; Koffigan M; Kora I; Ouvry D; Clavey V; Fruchart JC
    Clin Chem; 1984 Mar; 30(3):349-51. PubMed ID: 6697477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human apolipoproteins C by isoelectric focusing in immobilized pH gradients.
    Haase R; Menke-Möllers I; Oette K
    Electrophoresis; 1988 Sep; 9(9):569-75. PubMed ID: 3243252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I (Glu 198----Lys): a mutant of the major apolipoprotein of high-density lipoproteins occurring in a family with dyslipoproteinemia.
    Strobl W; Jabs HU; Hayde M; Holzinger T; Assmann G; Widhalm K
    Pediatr Res; 1988 Aug; 24(2):222-8. PubMed ID: 3141894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects.
    Huff MW; Fidge NH; Nestel PJ; Billington T; Watson B
    J Lipid Res; 1981 Nov; 22(8):1235-46. PubMed ID: 7320634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and quantification of apolipoproteins C-I, C-II, and C-III0-2 in very-low-density lipoproteins by "high-performance" anion-exchange chromatography.
    Weisweiler P; Friedl C; Schwandt P
    Clin Chem; 1986 Jun; 32(6):992-4. PubMed ID: 3708824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
    von Eckardstein A; Holz H; Sandkamp M; Weng W; Funke H; Assmann G
    J Clin Invest; 1991 May; 87(5):1724-31. PubMed ID: 2022742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T).
    Wiebusch H; Nofer JR; von Eckardstein A; Funke H; Wahrburg U; Martin H; Köhler E; Assmann G
    J Mol Med (Berl); 1995 Jul; 73(7):373-8. PubMed ID: 8520970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anion-exchange fast protein liquid chromatographic characterization and purification of apolipoproteins A-I, A-II, C-I, C-II, C-III0, C-III1, C-III2 and E from human plasma.
    Mezdour H; Clavey V; Kora I; Koffigan M; Barkia A; Fruchart JC
    J Chromatogr; 1987 Feb; 414(1):35-45. PubMed ID: 3106390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation and isolation of human apolipoproteins C-II, C-III0, C-III1, and C-III2 by chromatofocusing on the Fast Protein Liquid Chromatography system.
    Huff MW; Strong WL
    J Lipid Res; 1987 Sep; 28(9):1118-23. PubMed ID: 3655564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-II deficiency associated with nonfunctional mutant forms of apolipoprotein C-II.
    Maguire GF; Little JA; Kakis G; Breckenridge WC
    Can J Biochem Cell Biol; 1984 Sep; 62(9):847-52. PubMed ID: 6388756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of severe caloric restriction on the degree of sialylation of apoprotein C-III in obese women.
    Bosello O; Cominacini L; Zocca I; Garbin U; Ferrari F; Davoli A
    Ann Nutr Metab; 1985; 29(1):33-9. PubMed ID: 3977292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial apolipoprotein A-I and C-III deficiency, variant II.
    Schaefer EJ; Ordovas JM; Law SW; Ghiselli G; Kashyap ML; Srivastava LS; Heaton WH; Albers JJ; Connor WE; Lindgren FT
    J Lipid Res; 1985 Sep; 26(9):1089-101. PubMed ID: 3934306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surface charge of apolipoproteins, phospholipid liposomes, and human very low density lipoproteins.
    Heuck CC; Daerr W; Haberbosch W; Horn D; Lüddecke E
    J Biol Chem; 1983 Jul; 258(13):8317-22. PubMed ID: 6408088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing.
    Catapano AL; Jackson RL; Gilliam EB; Gotto AM; Smith LC
    J Lipid Res; 1978 Nov; 19(8):1047-52. PubMed ID: 32216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry.
    Jabs HU; Assmann G
    J Chromatogr; 1987 Mar; 414(2):323-33. PubMed ID: 3571400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin.
    Pullinger CR; Malloy MJ; Shahidi AK; Ghassemzadeh M; Duchateau P; Villagomez J; Allaart J; Kane JP
    J Lipid Res; 1997 Sep; 38(9):1833-40. PubMed ID: 9323592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apolipoprotein C-II variant apoC-IILys19-->Thr is not associated with dyslipidemia in an affected kindred.
    Zysow BR; Pullinger CR; Hennessy LK; Farese RV; Ghassemzadeh M; Kane JP
    Clin Genet; 1994 Jun; 45(6):292-7. PubMed ID: 7923858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.